MedPath
NMPA Approval

Paracetamol,Aminophenazone Phenacetin,Caffeine and Chlorphenamine Maleate Granules

国药准字H50021932

September 25, 2020

国药准字H50021932

Drug Information

酚氨咖敏颗粒

颗粒剂

复方

化学药品

September 25, 2020

Company Information

Applicant Company

重庆市万州区申明工业园区

Manufacturing Company

重庆市万州区申明工业园区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

酚氨咖敏颗粒 - NMPA 批准文号 | MedPath